Equities Analysts Offer Predictions for Maximus Q1 Earnings

Maximus, Inc. (NYSE:MMS) – Equities research analysts at Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for Maximus in a research note issued to investors on Wednesday, December 11th. Zacks Research analyst R. Department now expects that the health services provider will post earnings of $1.39 per share for the quarter, up from their previous forecast of $1.38. The consensus estimate for Maximus’ current full-year earnings is $5.89 per share. Zacks Research also issued estimates for Maximus’ Q2 2025 earnings at $1.44 EPS, Q3 2025 earnings at $1.50 EPS, Q4 2025 earnings at $1.52 EPS, FY2025 earnings at $5.84 EPS, Q2 2026 earnings at $1.19 EPS, Q3 2026 earnings at $1.45 EPS, Q4 2026 earnings at $1.23 EPS, FY2026 earnings at $5.05 EPS and FY2027 earnings at $5.29 EPS.

Separately, StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.

Maximus Stock Performance

Shares of MMS stock opened at $69.81 on Friday. Maximus has a 52 week low of $69.72 and a 52 week high of $93.97. The firm’s 50-day simple moving average is $82.58 and its two-hundred day simple moving average is $86.60. The firm has a market cap of $4.21 billion, a price-to-earnings ratio of 13.96 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. Maximus’s dividend payout ratio is 24.00%.

Insiders Place Their Bets

In related news, Director Raymond B. Ruddy acquired 3,490 shares of Maximus stock in a transaction on Thursday, December 12th. The shares were acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the transaction, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Maximus

A number of institutional investors have recently bought and sold shares of MMS. V Square Quantitative Management LLC bought a new stake in shares of Maximus during the 3rd quarter valued at $25,000. Blue Trust Inc. increased its stake in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 262 shares in the last quarter. Archer Investment Corp lifted its holdings in shares of Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after purchasing an additional 791 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after purchasing an additional 518 shares in the last quarter. Finally, Quarry LP increased its position in Maximus by 48.0% during the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock valued at $95,000 after buying an additional 330 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.